The 20 Best Hemangioma Thrombocytopenia Syndrome Doctors Near Me in Monroeville, PA
Find the Top Hemangioma Thrombocytopenia Syndrome Experts and Specialists
UPMC Hillman Cancer Center
Nishant Tageja, MD, is a medical oncologist and hematologist. Dr. Tageja specializes in the treatment of solid tumors such as breast cancer, lung cancer, and colon cancer as well as treatment of all benign and malignant blood disorders including lymphoma, leukemia, and myeloma. Dr. Tageja is rated as an Experienced provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Smoldering Multiple Myeloma, Familial Colorectal Cancer, Breast Cancer, Small Cell Lung Cancer (SCLC), and Bone Marrow Transplant. Dr. Tageja is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Tageja is currently accepting new patients.
UPMC Hillman Cancer Center
Khanh Nguyen, MD, specializes in medical oncology and practices with UPMC Hillman Cancer Center and is affiliated with UPMC East and UPMC Magee-Womens Hospital. Dr. Nguyen completed his medical education at the Medical College of Georgia and is board certified in Medical Oncology by the American Board of Internal Medicine. Dr. Nguyen is rated as an Experienced provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. Dr. Nguyen is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Nguyen is currently accepting new patients.
UPMC Hillman Cancer Center
Stanley Marks, MD, specializes in hematology oncology and medical oncology and is board-certified in hematology and internal medicine by the American Board of Internal medicine. Dr. Marks completed his medical degree at the University of Pittsburgh School of Medicine. He completed his residency training at Presbyterian Hospital, and fellowship training in clinical medicine and research medicine at Peter Bent Brigham Hospital, Harvard Medical School and Dana Farber Cancer Center. He has received numerous awards including the Golden Apple Award for Outstanding Dedication to Housestaff Education from Allegheny General Hospital, Hillel Academy Outstanding Alumnus, and The Winged Victory of Samothrace Award from the Leukemia, Lymphoma Society of Western Pennsylvania. Dr. Marks is rated as an Advanced provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Primary Lymphoma of the Brain, Gastric Lymphoma, and Follicular Lymphoma. Dr. Marks is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine.
UPMC Hillman Cancer Center
Jing-Zhou Hou, MD, PhD, is a clinical hematological oncologist specializing in hematological malignancies, cell therapy, and bone marrow transplant in the Mario Lemieux Center for Blood Cancers at UPMC Hillman Cancer Center. Dr. Hou received his medical degree from Henan Medical University in China, his master’s degree at Shanghai Medical University, and his PhD in Molecular and Cell Biology from Tulane University. He completed his internal medicine residency in Northeastern Ohio University College of Medicine, and fellowship in Hematology and Oncology at Stanford University. He joined UPMC Hillman Cancer Center in 2007. Dr. Hou is rated as an Advanced provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Hou is board certified in American Board Of Internal Medicine. Dr. Hou is currently accepting new patients.
UPMC Hillman Cancer Center, Independence Health System
John K. Waas, DO, is a medical oncologist at UPMC Hillman Cancer Center who practices at Arnold Palmer Medical Oncology at Norwin. Board-certified in medical oncology, Dr. Waas received his medical degree from Philadelphia College of Osteopathic Medicine in Philadelphia. He completed his residency at Lehigh Valley Hospital Center in Allentown, Pa. Dr. Waas is rated as a Distinguished provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Congenital Antithrombin 3 Deficiency, Protein C Deficiency, Hereditary Resistance to Anti-Vitamin K, and Protein S Deficiency. Dr. Waas is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Waas is currently accepting new patients.
Khan Medical Associates, LLC
Abdul Khan is a primary care provider, practicing in Internal Medicine in Pittsburgh, Pennsylvania. Dr. Khan is rated as an Experienced provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses End-Stage Renal Disease (ESRD), Hypertension, Glucocorticoid-Remediable Aldosteronism, Gastrostomy, and Endoscopy. Dr. Khan is board certified in American Board Of Internal Medicine. Dr. Khan is currently accepting new patients.
UPMC Hillman Cancer Center
Dr. Kane has practiced for more than 20 years and is board certified in Medical Oncology. He received his medical degree from Ohio State University School of Medicine. He completed his residency training in Hematology/Oncology at the University of Pittsburgh School of Medicine. Dr. Kane is rated as an Experienced provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Essential Thrombocythemia, Small Cell Lung Cancer (SCLC), and Familial Colorectal Cancer. Dr. Kane is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Kane is currently accepting new patients.
UPMC Hillman Cancer Center
Jason Bierenbaum, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Bierenbaum specializes in lung cancer, gastrointestinal cancers, and myelodysplasia. Dr. Bierenbaum is rated as an Experienced provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Familial Colorectal Cancer, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Bierenbaum is board certified in American Board Of Internal Medicine. Dr. Bierenbaum is currently accepting new patients.
UPMC Hillman Cancer Center
Andrew D. Laman, MD, is a hematologist and oncologist at UPMC Hillman Cancer Center. Dr. Laman specializes in hematology and medical oncology. Dr. Laman is rated as an Experienced provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC). Dr. Laman is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Laman is currently accepting new patients.
UPMC Hillman Cancer Center
Robert Redner is a Hematologist Oncology provider practicing medicine in Pittsburgh, Pennsylvania. Dr. Redner is rated as an Experienced provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Redner is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Redner is currently accepting new patients.
UPMC Hillman Cancer Center
James M. Rossetti, DO, is a hematologist specializing in the treatment of hematological malignancies and myeloid diseases, including myelodysplasia, acute myeloid leukemia, and myeloproliferative neoplasm. He also specializes in cellular therapy. Dr. Rossetti is a referral physician for the UPMC MDS Center of Excellence. Dr. Rossetti is rated as an Experienced provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Multiple Myeloma, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Rossetti is board certified in American Board Of Internal Medicine. Dr. Rossetti is currently accepting new patients.
UPMC Hillman Cancer Center
Donald Woytowitz, Jr., MD, is a hematologist/oncologist at UPMC Hillman Cancer Center. He specializes in myeloproliferative disorders, myelodysplastic syndromes, benign hematology, and non-Hodgkin lymphoma. Dr. Woytowitz is rated as an Experienced provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. His clinical expertise encompasses Polycythemia Vera, Thrombocytopenia, Essential Thrombocythemia, and Schnitzler Syndrome. Dr. Woytowitz is board certified in American Board Of Internal Medicine. Dr. Woytowitz is currently accepting new patients.
UPMC Hillman Cancer Center
John C. Rhee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Rhee is skilled in the management of all forms of cancer and blood diseases, with particular interest in cancers of the gastrointestinal tract and chest, including colorectal, esophageal, gastric, pancreaticobiliary, liver, neuroendocrine, and lung tumors. Dr. Rhee is rated as an Experienced provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Pancreatic Cancer, Small Cell Lung Cancer (SCLC), Gamma Knife Radiosurgery, and Gastrostomy. Dr. Rhee is board certified in American Board Of Internal Medicine. Dr. Rhee is currently accepting new patients.
UPMC Hillman Cancer Center
Jaime Mullin, DO, is a medical oncologist at UPMC Hillman Cancer Center. Dr. Mullin is rated as an Experienced provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Posterior Fossa Tumor, Pleuropulmonary Blastoma, Gamma Knife Radiosurgery, and Gastrostomy. Dr. Mullin is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine.
Office
Hyoung Kim is a Hematologist practicing medicine in Irwin, Pennsylvania. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, and Childhood Iron Deficiency Anemia.
Oncology-Hematology Association
Min Sun, MD, PhD, is an oncologist and hematologist at UPMC. He specializes in the clinical care of breast cancer patients and those at high-risk for breast cancer. He also researches breast cancer tumor markers and early diagnosis. Dr. Sun is rated as an Experienced provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Familial Colorectal Cancer. Dr. Sun is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Sun is currently accepting new patients.
Classical Hematology
Roy E. Smith, MD, is a professor of medicine at the University of Pittsburgh School of Medicine in the Division of Hematology/Oncology. Dr Smith specializes in bleeding and thrombotic disorders, Rare Homologic Diseases, Chronic Leukemia and Myelodyplasia.Dr. Smith is board-certified in internal medicine, medical oncology, and hematology. He received his medical degree from The Ohio State University, Columbus, and his Master of Science degree from the University of Wisconsin, College of Medicine, Madison. He completed his residency in medical oncology and his fellowship in hematology oncology, both at The Ohio State University. He is the former director of the Ohio State University Hospital's Special Coagulation Laboratory and its Hemophilia Center. He presently serves as chairman of the Central Investigational Review Board for the Cancer Therapeutics and Development branch of the National Cancer Institute and has served on the Peripheral and Central Nervous System Drug Advisory Committee and the Oncologic Drug Advisory Committee of the FDA. Dr. Smith serves as the co-chair of the Anticoagulation Task Force for the Presbyterian Hospital and its affiliates and chair of the Anticoagulation Working Group of the system-wide P and T committee.Dr. Smith is a member of the American Society of Hematology, the American Society of Clinical Oncology, the Society for Scientific Exploration, The International Society of Thrombosis and Hemostasis, the American Medical Association and the American Society for Apheresis, and the American College of Chest Physicians. He is a Fellow of the American College of Physicians and the International Academy of Clinical and Applied Thrombosis and Hemostasis. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Acute Hepatic Porphyria (AHP), Shwartzman Phenomenon, Porphyria, and Venous Thromboembolism (VTE). Dr. Smith is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Smith is currently accepting new patients.
UPMC Hillman Cancer Center
Shannon L. Puhalla, MD, is assistant professor of medicine at the University of Pittsburgh School of Medicine, and a medical oncologist and hematologist at UPMC Hillman Cancer Center. She specializes in breast oncology, Phase I clinical trials, and novel therapeutics in breast cancer. Dr. Puhalla is rated as an Experienced provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma. Dr. Puhalla is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Puhalla is currently accepting new patients.
UPMC Presbyterian
Robert Volkin is a Hematologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Volkin is rated as a Distinguished provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, Gastric Lymphoma, and Inflammatory Breast Cancer.
Office
Jason Thomas is an Oncologist practicing medicine in Monroeville, Pennsylvania. Dr. Thomas is rated as an Experienced provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Cancer, and Pulmonary Embolism.
Last Updated: 04/28/2026
















